Klacid Iv

Clarithromycin, the active ingredient in Klacid Iv, is a macrolide antibiotic presented as an intravenous solution for intravenous use. It treats a range of bacterial infections, particularly respiratory and skin infections, in adult and pediatric patients as prescribed by a healthcare professional.

GNH USA supplies Klacid Iv as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Clarithromycin is a macrolide antibiotic used to treat bacterial infections affecting the respiratory tract, sinuses, skin and gastrointestinal system. - Community‑acquired pneumonia: eradicates the causative bacteria and improves lung function. - Acute bacterial sinusitis: reduces sinus inflammation and clears infection. - Acute bacterial exacerbation of chronic bronchitis: shortens symptom duration and prevents complications. - Skin and soft tissue infections: eliminates pathogenic bacteria and promotes healing. - Helicobacter pylori eradication: part of combination therapy to eradicate H. pylori infection.

Clarithromycin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: frequent loose stools. - Abdominal pain: cramping or discomfort. - Altered taste: metallic or bitter sensation. - Headache: mild persistent pain. - Rash: mild skin irritation.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Clostridioides difficile‑associated diarrhea: severe colitis. - Elevated liver enzymes: potential hepatotoxicity. - QT interval prolongation: risk of cardiac arrhythmia. - Stevens‑Johnson syndrome: severe skin and mucous membrane disorder. - Hepatobiliary dysfunction: jaundice or liver injury.

Before initiating therapy, clinicians should consider several safety measures. - Assess renal function: adjust therapy in severe renal impairment. - Monitor liver enzymes: watch for signs of hepatotoxicity. - Review concomitant medications: avoid drugs that prolong QT interval. - Avoid use in patients with known macrolide hypersensitivity. - Use caution in patients with pre‑existing cardiac arrhythmias. - Store at room temperature: keep in original container, protect from light and moisture.

Clarithromycin interacts with several medicines; awareness helps prevent adverse events.

Major Interactions (Avoid): - Cisapride: may cause serious arrhythmias. - Pimozide: risk of severe QT prolongation. - Erythromycin or other macrolides: additive QT prolongation.

Moderate Interactions (Monitor Closely): - Warfarin: increased anticoagulant effect, monitor INR. - Simvastatin or lovastatin: elevated statin levels, monitor for myopathy. - Theophylline: increased plasma concentrations, watch for toxicity.